Spotlight welcomes ODI Pharma
A warm welcome to ODI Pharma on their first day as a listed company!
ODI Pharma is a manufacturer and supplier of medical cannabis products. The business is run through subsidiaries and partners where sales are executed through wholesale distributors and pharmacies. The products are used in the treatment of multiple sclerosis, chronic pain and in chemotherapy. Business operations are mainly located in the European market, with the head office in Stockholm.
“We are happy to welcome ODI Pharma to Spotlight and we will continue to be a dedicated partner on their journey” says Peter Gönczi, CEO Spotlight.
Press contact
Jenny Sondal, CMO Spotlight
+46 70 7749303, js@spotlightstockmarket.com
WHY SPOTLIGHT
Spotlight is the marketplace where investors and growth companies meet. At Spotlight it is easier and safer for companies to be listed. We offer a overall solution that increase the visibility for our companies through unique media collaborations. Investors get through Spotlight the opportunity to become shareholders in more than 170 growth companies from different businesses and countries, among those are Freetrailer, Hamlet Pharma and Synthetic MR.
